948859-54-9Relevant articles and documents
A versatile route to C-6 arylmethyl-functionalized S-DABO and related analogues
Radi, Marco,Contemori, Lorenzo,Castagnolo, Daniele,Spinosa, Raffaella,Este, Jose A.,Massa, Silvio,Botta, Maurizio
, p. 3157 - 3160 (2008/02/10)
Since their discovery in 1992,3,4-dihydro-2-alkoxy-6-benzyl-4- oxypyrimidines (DABOs) have been subjected to many structural modifications in order to obtain better non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of AIDS. Herein